Asia Pacific Oligonucleotide Synthesis Market

The Asia Pacific oligonucleotide synthesis market is expected to reach US$ 872.98 Mn in 2027 from US$ 334.26 Mn in 2018 the market is estimated to grow with a CAGR of 14.7% from 2019-2027.

The growth of the Oligonucleotide Synthesis market is driven by the factors such as, the growing use of synthesized oligonucleotides and government support for biotechnology research in Asia Pacific. However, the market is likely to slower down its growth due to dearth of skilled professional in the region.

The high growth of the market is anticipated on account of the rise in the investment are enabling technological developments and standard biological parts. For Instance, The Biotechnology Industry Research Assistance Council (BIRAC) is a public entity developed by the DBT, government of India, which aims to strengthen and empower the emerging biotech enterprises. DBT along with the BIRAC plays important role in transforming the biotech sector by Make in India and Startup India and the aim is to inform the India Bioeconomy to US$ 100 billion by the 2025. Developments such as partnerships and increasing focus on synthetic biology research is expected to contribute to the growth of the market.

Japan is expected to lead the market in the Asia Pacific region owing to the rising prevalence of chronic diseases such as coronary diseases & cancer and increase in awareness regarding cancer in the country. Moreover the government initiative for research activities, collaboration among major player in country. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Asia Pacific region during the forecast period.

Rest of Asia Pacific Oligonucleotide Synthesis Market Revenue and Forecasts to 2027 (US$ Mn)

Asia Pacific Oligonucleotide Synthesis Strategic Insights

Strategic insights for the Asia Pacific Oligonucleotide Synthesis provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Asia Pacific Oligonucleotide Synthesis Report Scope

Asia Pacific Oligonucleotide Synthesis Regional Insights

The geographic scope of the Asia Pacific Oligonucleotide Synthesis refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

ASIA PACIFIC OLIGONUCLEOTIDE SYNTHESIS – MARKET SEGMENTATION

By Product

• Synthesized Oligonucleotides
  • Primers
  • Probes
  • Large-Scale Synthesis
  • Others
• Reagents
• Equipment

By Application

• Research
• Diagnostics
• Therapeutics

By

End User

• Academic Research Institutes
• Pharmaceutical & Biotechnology Companies
• Diagnostic Laboratories
• Other End Users

By Geography

• Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea

Company Profiles

• Molecular Assemblies
• Twist Bioscience
• Evonetix
• Nuclera Nucleics Ltd
• Camena Bio
• DNA Script
• Iridia, Inc.,
• Helixworks
• Ansa Biotechnologies, Inc.,
• Synthomics, Inc.,